流式细胞术 – Medxy AI

Bone Marrow Immune Profiling Identifies a Practical Infection Risk Score in Multiple Myeloma

By MedXY 05/09/2026

A large multicenter study links specific bone marrow immune cell patterns to infection risk in multiple myeloma and proposes a clinically relevant immune score that may support minimally invasive monitoring.

Hematology-Oncology news

Immunophenotypic Evolution and Clinical Outcomes in R/R AML Treated with Revumenib

By MedXY 03/29/2026

A study of 48 patients with R/R AML treated with revumenib revealed that 52% experienced dynamic immunophenotypic changes. Achieving MRD-negative morphologic remission significantly improved overall survival, highlighting the necessity for specialized flow cytometry monitoring during menin inhibitor therapy.

Clinical Updates Hematology-Oncology news Pathology & Lab Medicine

Improving Survival in Advanced Proliferative CMML: The Prognostic Impact of Stringent Cytoreduction and Novel Flow Cytometric Biomarkers

By MedXY 03/19/2026

This review examines the impact of myeloproliferative control on survival in advanced CMML, highlighting the prognostic value of stringent cytoreduction and novel flow cytometric biomarkers such as classical monocytes and immature granulocytes.